The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ertapenem Injection-Global Market Insights and Sales Trends 2025
Synopsis
Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.
The global Ertapenem Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ertapenem Injection in various end use industries. The expanding demands from the Adult and Pediatric, are propelling Ertapenem Injection market. 1g/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ertapenem Injection market, driven by demand from China, the second largest economy with some signs of stabilising, the Ertapenem Injection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ertapenem Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ertapenem Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ertapenem Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ertapenem Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ertapenem Injection covered in this report include Merck, Endo, Aurobindo Pharma and ACS Dobfar, etc.
The global Ertapenem Injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Endo
Aurobindo Pharma
ACS Dobfar
Global Ertapenem Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ertapenem Injection market, Segment by Type:
1g/Vial
Others
Global Ertapenem Injection market, by Application
Adult
Pediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ertapenem Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ertapenem Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.
The global Ertapenem Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ertapenem Injection in various end use industries. The expanding demands from the Adult and Pediatric, are propelling Ertapenem Injection market. 1g/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ertapenem Injection market, driven by demand from China, the second largest economy with some signs of stabilising, the Ertapenem Injection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ertapenem Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ertapenem Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ertapenem Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ertapenem Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ertapenem Injection covered in this report include Merck, Endo, Aurobindo Pharma and ACS Dobfar, etc.
The global Ertapenem Injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Endo
Aurobindo Pharma
ACS Dobfar
Global Ertapenem Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ertapenem Injection market, Segment by Type:
1g/Vial
Others
Global Ertapenem Injection market, by Application
Adult
Pediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ertapenem Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ertapenem Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Ertapenem Injection Market Overview
1.1 Ertapenem Injection Product Overview
1.2 Ertapenem Injection Market Segment by Type
1.2.1 1g/Vial
1.2.2 Others
1.3 Global Ertapenem Injection Market Size by Type
1.3.1 Global Ertapenem Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Ertapenem Injection Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ertapenem Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ertapenem Injection Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ertapenem Injection Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ertapenem Injection Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ertapenem Injection Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ertapenem Injection Sales Breakdown by Type (2018-2023)
2 Global Ertapenem Injection Market Competition by Company
2.1 Global Top Players by Ertapenem Injection Sales (2018-2023)
2.2 Global Top Players by Ertapenem Injection Revenue (2018-2023)
2.3 Global Top Players by Ertapenem Injection Price (2018-2023)
2.4 Global Top Manufacturers Ertapenem Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ertapenem Injection Market Competitive Situation and Trends
2.5.1 Ertapenem Injection Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ertapenem Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ertapenem Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Ertapenem Injection Market
2.8 Key Manufacturers Ertapenem Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ertapenem Injection Status and Outlook by Region
3.1 Global Ertapenem Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ertapenem Injection Historic Market Size by Region
3.2.1 Global Ertapenem Injection Sales in Volume by Region (2018-2023)
3.2.2 Global Ertapenem Injection Sales in Value by Region (2018-2023)
3.2.3 Global Ertapenem Injection Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ertapenem Injection Forecasted Market Size by Region
3.3.1 Global Ertapenem Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Ertapenem Injection Sales in Value by Region (2024-2029)
3.3.3 Global Ertapenem Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ertapenem Injection by Application
4.1 Ertapenem Injection Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric
4.2 Global Ertapenem Injection Market Size by Application
4.2.1 Global Ertapenem Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Ertapenem Injection Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ertapenem Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ertapenem Injection Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ertapenem Injection Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ertapenem Injection Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ertapenem Injection Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ertapenem Injection Sales Breakdown by Application (2018-2023)
5 North America Ertapenem Injection by Country
5.1 North America Ertapenem Injection Historic Market Size by Country
5.1.1 North America Ertapenem Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ertapenem Injection Sales in Volume by Country (2018-2023)
5.1.3 North America Ertapenem Injection Sales in Value by Country (2018-2023)
5.2 North America Ertapenem Injection Forecasted Market Size by Country
5.2.1 North America Ertapenem Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Ertapenem Injection Sales in Value by Country (2024-2029)
6 Europe Ertapenem Injection by Country
6.1 Europe Ertapenem Injection Historic Market Size by Country
6.1.1 Europe Ertapenem Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ertapenem Injection Sales in Volume by Country (2018-2023)
6.1.3 Europe Ertapenem Injection Sales in Value by Country (2018-2023)
6.2 Europe Ertapenem Injection Forecasted Market Size by Country
6.2.1 Europe Ertapenem Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Ertapenem Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Ertapenem Injection by Region
7.1 Asia-Pacific Ertapenem Injection Historic Market Size by Region
7.1.1 Asia-Pacific Ertapenem Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ertapenem Injection Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ertapenem Injection Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ertapenem Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Ertapenem Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ertapenem Injection Sales in Value by Region (2024-2029)
8 Latin America Ertapenem Injection by Country
8.1 Latin America Ertapenem Injection Historic Market Size by Country
8.1.1 Latin America Ertapenem Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ertapenem Injection Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ertapenem Injection Sales in Value by Country (2018-2023)
8.2 Latin America Ertapenem Injection Forecasted Market Size by Country
8.2.1 Latin America Ertapenem Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ertapenem Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Ertapenem Injection by Country
9.1 Middle East and Africa Ertapenem Injection Historic Market Size by Country
9.1.1 Middle East and Africa Ertapenem Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ertapenem Injection Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ertapenem Injection Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ertapenem Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Ertapenem Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ertapenem Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Ertapenem Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Ertapenem Injection Products Offered
10.1.5 Merck Recent Development
10.2 Endo
10.2.1 Endo Company Information
10.2.2 Endo Introduction and Business Overview
10.2.3 Endo Ertapenem Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Endo Ertapenem Injection Products Offered
10.2.5 Endo Recent Development
10.3 Aurobindo Pharma
10.3.1 Aurobindo Pharma Company Information
10.3.2 Aurobindo Pharma Introduction and Business Overview
10.3.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Aurobindo Pharma Ertapenem Injection Products Offered
10.3.5 Aurobindo Pharma Recent Development
10.4 ACS Dobfar
10.4.1 ACS Dobfar Company Information
10.4.2 ACS Dobfar Introduction and Business Overview
10.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue and Gross Margin (2018-2023)
10.4.4 ACS Dobfar Ertapenem Injection Products Offered
10.4.5 ACS Dobfar Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ertapenem Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ertapenem Injection Industrial Chain Analysis
11.4 Ertapenem Injection Market Dynamics
11.4.1 Ertapenem Injection Industry Trends
11.4.2 Ertapenem Injection Market Drivers
11.4.3 Ertapenem Injection Market Challenges
11.4.4 Ertapenem Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ertapenem Injection Distributors
12.3 Ertapenem Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
